The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Trimel Pharmaceuticals Corp

TSX: TRL
Delayed quote

$0.45

Today's change+0.01 +2.27%
Updated August 28 3:50 PM EDT. Delayed by at least 15 minutes.
 

Trimel Pharmaceuticals Corp

TSX: TRL
Delayed quote

$0.45

Today's change+0.01 +2.27%
Updated August 28 3:50 PM EDT. Delayed by at least 15 minutes.

Trimel Pharmaceuticals Corp up sharply

Trimel Pharmaceuticals Corp closed up sharply Friday, rallying $0.01 or 2.27% to $0.45. Over the last five days, shares have gained 9.76%, but are down 35.71% for the last year to date. Shares have outperformed the S&P TSX by 4.63% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.10
Updated August 28 3:50 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue3332
Total other revenue--------
Total revenue3332
Gross profit21-50
Total cost of revenue1272
Total operating expense3497
Selling / general / administrative2111
Research & development1111
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)0002
Other operating expenses, total----0--
Operating income-1-1-7-5
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-8-5
Income after tax-20-8-5
Income tax, total0000
Net income-20-8-5
Total adjustments to net income----0--
Net income before extra. items-20-8-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-8-5
Inc. avail. to common incl. extra. items-20-8-5
Diluted net income-20-8-5
Dilution adjustment000--
Diluted weighted average shares201201201186
Diluted EPS excluding extraordinary itemsvalue per share-0.010.00-0.04-0.02
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.010.00-0.04-0.01